HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-DEC-17 6BSD TITLE DDR1 BOUND TO DASATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, RESIDUES 526-876; COMPND 5 SYNONYM: EPITHELIAL DISCOIDIN DOMAIN RECEPTOR 1,CD167 ANTIGEN-LIKE COMPND 6 FAMILY MEMBER A,CELL ADHESION KINASE,DISCOIDIN RECEPTOR TYROSINE COMPND 7 KINASE,HGK2,MAMMARY CARCINOMA KINASE 10,MCK-10,PROTEIN-TYROSINE COMPND 8 KINASE 3A,PROTEIN-TYROSINE KINASE RTK-6,TRK E,TYROSINE KINASE DDR, COMPND 9 TYROSINE-PROTEIN KINASE CAK; COMPND 10 EC: 2.7.10.1; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1711 KEYWDS KINASE, INHIBITOR, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.GEORGHIOU,M.A.SEELIGER REVDAT 6 25-OCT-23 6BSD 1 REMARK REVDAT 5 12-APR-23 6BSD 1 COMPND SOURCE REMARK DBREF REVDAT 5 2 1 SEQRES HELIX SHEET SITE REVDAT 5 3 1 ATOM REVDAT 4 23-MAR-22 6BSD 1 REMARK REVDAT 3 19-JUN-19 6BSD 1 JRNL REVDAT 2 20-FEB-19 6BSD 1 REMARK REVDAT 1 05-DEC-18 6BSD 0 JRNL AUTH S.M.HANSON,G.GEORGHIOU,M.K.THAKUR,W.T.MILLER,J.S.REST, JRNL AUTH 2 J.D.CHODERA,M.A.SEELIGER JRNL TITL WHAT MAKES A KINASE PROMISCUOUS FOR INHIBITORS? JRNL REF CELL CHEM BIOL V. 26 390 2019 JRNL REFN ESSN 2451-9456 JRNL PMID 30612951 JRNL DOI 10.1016/J.CHEMBIOL.2018.11.005 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 10656 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.870 REMARK 3 FREE R VALUE TEST SET COUNT : 1052 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.5534 - 5.2095 1.00 1283 145 0.1808 0.2448 REMARK 3 2 5.2095 - 4.1357 1.00 1221 130 0.1489 0.1993 REMARK 3 3 4.1357 - 3.6131 1.00 1196 134 0.1565 0.2447 REMARK 3 4 3.6131 - 3.2829 1.00 1190 132 0.1718 0.2574 REMARK 3 5 3.2829 - 3.0476 1.00 1192 125 0.1951 0.2874 REMARK 3 6 3.0476 - 2.8679 1.00 1179 134 0.2151 0.3082 REMARK 3 7 2.8679 - 2.7243 1.00 1182 125 0.2123 0.3096 REMARK 3 8 2.7243 - 2.6057 0.98 1161 127 0.2360 0.3191 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2302 REMARK 3 ANGLE : 1.162 3114 REMARK 3 CHIRALITY : 0.039 335 REMARK 3 PLANARITY : 0.005 401 REMARK 3 DIHEDRAL : 16.145 865 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BSD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1000231326. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10658 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.606 REMARK 200 RESOLUTION RANGE LOW (A) : 47.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 0.17400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4BKJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 3350 AND 0.1 M BIS-TRIS PH REMARK 280 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.83450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.32800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.17100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.32800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.83450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.17100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 526 REMARK 465 ASN A 527 REMARK 465 SER A 528 REMARK 465 VAL A 529 REMARK 465 PRO A 530 REMARK 465 HIS A 531 REMARK 465 TYR A 532 REMARK 465 ALA A 533 REMARK 465 GLU A 534 REMARK 465 ALA A 535 REMARK 465 ASP A 536 REMARK 465 ILE A 537 REMARK 465 VAL A 538 REMARK 465 THR A 539 REMARK 465 LEU A 540 REMARK 465 GLN A 541 REMARK 465 GLY A 542 REMARK 465 VAL A 543 REMARK 465 THR A 544 REMARK 465 GLY A 545 REMARK 465 GLY A 546 REMARK 465 ASN A 547 REMARK 465 THR A 548 REMARK 465 TYR A 549 REMARK 465 ALA A 550 REMARK 465 VAL A 551 REMARK 465 PRO A 552 REMARK 465 ALA A 553 REMARK 465 LEU A 554 REMARK 465 PRO A 555 REMARK 465 PRO A 556 REMARK 465 GLY A 557 REMARK 465 ALA A 558 REMARK 465 VAL A 559 REMARK 465 GLY A 560 REMARK 465 ASP A 561 REMARK 465 GLY A 562 REMARK 465 PRO A 563 REMARK 465 PRO A 564 REMARK 465 ARG A 565 REMARK 465 VAL A 566 REMARK 465 PRO A 595 REMARK 465 GLN A 596 REMARK 465 ASP A 597 REMARK 465 LEU A 598 REMARK 465 VAL A 599 REMARK 465 SER A 600 REMARK 465 LEU A 601 REMARK 465 ASP A 602 REMARK 465 PHE A 603 REMARK 465 PRO A 604 REMARK 465 LEU A 605 REMARK 465 ASN A 606 REMARK 465 VAL A 607 REMARK 465 ARG A 608 REMARK 465 LYS A 609 REMARK 465 GLY A 610 REMARK 465 HIS A 611 REMARK 465 ALA A 686 REMARK 465 GLU A 687 REMARK 465 GLY A 688 REMARK 465 ALA A 689 REMARK 465 PRO A 690 REMARK 465 GLY A 691 REMARK 465 ASP A 692 REMARK 465 GLY A 693 REMARK 465 GLN A 694 REMARK 465 ALA A 695 REMARK 465 ALA A 696 REMARK 465 GLN A 697 REMARK 465 MET A 750 REMARK 465 SER A 751 REMARK 465 VAL A 876 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 570 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 577 CG CD OE1 OE2 REMARK 470 ARG A 752 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 753 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 699 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 728 -4.33 83.98 REMARK 500 ASP A 729 49.07 -155.86 REMARK 500 PHE A 748 170.82 174.69 REMARK 500 GLU A 870 -70.75 -124.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1N1 A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6BRJ RELATED DB: PDB DBREF 6BSD A 526 876 UNP Q08345 DDR1_HUMAN 526 876 SEQRES 1 A 351 GLN ASN SER VAL PRO HIS TYR ALA GLU ALA ASP ILE VAL SEQRES 2 A 351 THR LEU GLN GLY VAL THR GLY GLY ASN THR TYR ALA VAL SEQRES 3 A 351 PRO ALA LEU PRO PRO GLY ALA VAL GLY ASP GLY PRO PRO SEQRES 4 A 351 ARG VAL ASP PHE PRO ARG SER ARG LEU ARG PHE LYS GLU SEQRES 5 A 351 LYS LEU GLY GLU GLY GLN PHE GLY GLU VAL HIS LEU CYS SEQRES 6 A 351 GLU VAL ASP SER PRO GLN ASP LEU VAL SER LEU ASP PHE SEQRES 7 A 351 PRO LEU ASN VAL ARG LYS GLY HIS PRO LEU LEU VAL ALA SEQRES 8 A 351 VAL LYS ILE LEU ARG PRO ASP ALA THR LYS ASN ALA ARG SEQRES 9 A 351 ASN ASP PHE LEU LYS GLU VAL LYS ILE MET SER ARG LEU SEQRES 10 A 351 LYS ASP PRO ASN ILE ILE ARG LEU LEU GLY VAL CYS VAL SEQRES 11 A 351 GLN ASP ASP PRO LEU CYS MET ILE THR ASP TYR MET GLU SEQRES 12 A 351 ASN GLY ASP LEU ASN GLN PHE LEU SER ALA HIS GLN LEU SEQRES 13 A 351 GLU ASP LYS ALA ALA GLU GLY ALA PRO GLY ASP GLY GLN SEQRES 14 A 351 ALA ALA GLN GLY PRO THR ILE SER TYR PRO MET LEU LEU SEQRES 15 A 351 HIS VAL ALA ALA GLN ILE ALA SER GLY MET ARG TYR LEU SEQRES 16 A 351 ALA THR LEU ASN PHE VAL HIS ARG ASP LEU ALA THR ARG SEQRES 17 A 351 ASN CYS LEU VAL GLY GLU ASN PHE THR ILE LYS ILE ALA SEQRES 18 A 351 ASP PHE GLY MET SER ARG ASN LEU TYR ALA GLY ASP TYR SEQRES 19 A 351 TYR ARG VAL GLN GLY ARG ALA VAL LEU PRO ILE ARG TRP SEQRES 20 A 351 MET ALA TRP GLU CYS ILE LEU MET GLY LYS PHE THR THR SEQRES 21 A 351 ALA SER ASP VAL TRP ALA PHE GLY VAL THR LEU TRP GLU SEQRES 22 A 351 VAL LEU MET LEU CYS ARG ALA GLN PRO PHE GLY GLN LEU SEQRES 23 A 351 THR ASP GLU GLN VAL ILE GLU ASN ALA GLY GLU PHE PHE SEQRES 24 A 351 ARG ASP GLN GLY ARG GLN VAL TYR LEU SER ARG PRO PRO SEQRES 25 A 351 ALA CYS PRO GLN GLY LEU TYR GLU LEU MET LEU ARG CYS SEQRES 26 A 351 TRP SER ARG GLU SER GLU GLN ARG PRO PRO PHE SER GLN SEQRES 27 A 351 LEU HIS ARG PHE LEU ALA GLU ASP ALA LEU ASN THR VAL HET 1N1 A 901 33 HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETSYN 1N1 DASATINIB FORMUL 2 1N1 C22 H26 CL N7 O2 S FORMUL 3 HOH *61(H2 O) HELIX 1 AA1 PRO A 569 SER A 571 5 3 HELIX 2 AA2 THR A 625 SER A 640 1 16 HELIX 3 AA3 ASP A 671 ALA A 678 1 8 HELIX 4 AA4 SER A 702 LEU A 723 1 22 HELIX 5 AA5 ALA A 731 ARG A 733 5 3 HELIX 6 AA6 TYR A 755 TYR A 759 5 5 HELIX 7 AA7 PRO A 769 MET A 773 5 5 HELIX 8 AA8 ALA A 774 GLY A 781 1 8 HELIX 9 AA9 THR A 784 MET A 801 1 18 HELIX 10 AB1 THR A 812 ASP A 826 1 15 HELIX 11 AB2 PRO A 840 CYS A 850 1 11 HELIX 12 AB3 GLU A 854 ARG A 858 5 5 HELIX 13 AB4 PRO A 860 GLU A 870 1 11 HELIX 14 AB5 ASP A 871 ASN A 874 5 4 SHEET 1 AA1 5 LEU A 573 GLU A 581 0 SHEET 2 AA1 5 GLY A 585 VAL A 592 -1 O VAL A 587 N GLY A 580 SHEET 3 AA1 5 LEU A 613 LEU A 620 -1 O VAL A 617 N HIS A 588 SHEET 4 AA1 5 CYS A 661 ASP A 665 -1 O THR A 664 N ALA A 616 SHEET 5 AA1 5 LEU A 650 CYS A 654 -1 N LEU A 651 O ILE A 663 SHEET 1 AA2 2 GLN A 680 LEU A 681 0 SHEET 2 AA2 2 THR A 700 ILE A 701 1 O ILE A 701 N GLN A 680 SHEET 1 AA3 2 CYS A 735 VAL A 737 0 SHEET 2 AA3 2 ILE A 743 ILE A 745 -1 O LYS A 744 N LEU A 736 CISPEP 1 ASP A 658 PRO A 659 0 -0.66 SITE 1 AC1 14 LEU A 579 VAL A 587 ALA A 616 LYS A 618 SITE 2 AC1 14 GLU A 635 ILE A 648 THR A 664 ASP A 665 SITE 3 AC1 14 TYR A 666 MET A 667 GLU A 668 GLY A 670 SITE 4 AC1 14 LEU A 736 ASP A 747 CRYST1 61.669 72.342 74.656 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016216 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013823 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013395 0.00000